| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Paravasthu Mukund | Chief Operating Officer | C/O NOVOCURE INC., 1550 LIBERTY RIDGE DRIVE, SUITE 115, WAYNE | Steven Robbins, as attorney in fact for Paravasthu, Mukund | 03 Mar 2026 | 0002039078 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | NVCR | Ordinary Shares | Sale | $21,247 | -1,555 | -2% | $13.66 | 76,751 | 27 Feb 2026 | Direct | F1, F2 |
| transaction | NVCR | Ordinary Shares | Sale | $5,505 | -408 | -0.53% | $13.49 | 76,343 | 02 Mar 2026 | Direct | F1, F3 |
| Id | Content |
|---|---|
| F1 | Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. |
| F2 | This transaction was executed in multiple trades at prices ranging from $13.45 USD to $13.97 USD; the price reported above reflects the weighted average sale price. |
| F3 | This transaction was executed in multiple trades at prices ranging from $13.3126 USD to $13.70 USD; the price reported above reflects the weighted average sale price. |